Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hydrogels are still in play for stem cell applications.
If this goes up like it went down, it'll be the stock of the century..
Open market purchase from a biotech at the developmental stage is not an indicator.....unless it is an indicator of manipulation....
This is going to go so high, they will be testing the procedure in a weightless environment.
Thanks Elysee....I think we do have an understanding!
your response forces me to think more realistically....even while I know that the RPE revenue stream is only an eventually a small part of the revenue stream, and a more realistic valuation would render a PPS closer to 15,000 to 20,000 PPS....yes I might as you say, knuckle under to the offer of a sell all at 4500pps......private message me so we can sort this out.
I would also sell some at $4500/share.....but not all.
Let's think conservatively then, 450 per share....
So you don't think a pps of 4,500 is conservative?
I look forward to more frequent results being shared during phase II
Really nice video....very clean presentation....easy for the layman to understand.
That is a good one! electrical storage has always been a weak link in the intermittent production of electricity. How will XsnX find its way?
How is the neo kidney augment doing?
Expansion
So anticipated, another link from ACTC Website
http://ir.advancedcell.com/press-releases/detail/2604/act-announces-positive-results-from-two-clinical-trials
A shelf offering is an offering of new securities that are released to the public market incrementally over a period of time.
A company must first complete a shelf registration with the Securities and Exchange Commission (SEC) before it begins its shelf offering.
How it works/Example:
Under Rule 415, the SEC allows an issuer to register new securities, and then shelve the public offering for up to two years. This lets the company make a public offering any time it wants. During this time, any shares of unreleased stock are not treated as shares outstanding for purpose of valuing the company.
Because of the lead time involved in the registration process, a shelf offering allows a company to act quickly when the time is right to issue additional shares in the market, which can be a huge advantage. A company can use a shelf offering to its benefit by waiting for favorable market conditions to release shares.
Why it Matters:
A shelf offering provides a business with the maximum amount of control over the process of offering new shares. It allows the company to control the shares' price by allowing the issuer to manage the supply of its security in the market. It also allows the issuer to gauge and time the release of its stock, which is especially beneficial if the market is volatile. Lastly, a shelf offering allows a company to save on the cost of registration with the SEC by not having to re-register each time it wants to release new shares.
They had a 10 for 1 reverse split a couple of years ago, desperate to state listed, didn't make it. Delisted and has augured in here in penny land. They are trying prayer circles.
I like the way google finance has ACTC market cap at 26.02 billion.
https://www.google.com/finance?q=OTCMKTS%3AACTC&ei=LmklVJibHoekqwHb-IH4Cw
Oh Geez....we got another one.
I wonder if this means new contracts are signed?
"name something that can be corroborated" What r you doing there Jonnyboy, putting them on trial?
I will vote yes. When you take a look at a list of what they have done, it is quite impressive. Seems like some folks like to constantly harp on them as if the company is a slacker type person. How many of you respond well to this type of approach?
The comments regarding the recent interest that Advanced Cell Technology has in increasing shares approved have mostly been one sided. But this excerpt from today's SA article by Esekla has a different take on the matter. Here is that excerpt:
In this case, I speculate that the bulk of new shares would be used in a private placement with an established pharmaceutical firm in order to form a joint venture. This is step 5 of the process I outlined for the company, which is now halfway complete. While the same thing could have been accomplished with a revenue sharing contract, which technically would have been non-dilutive, the practical effect would have been the same, and this approach is likely far more palatable to prospective partners. The new shares represent 40% dilution for existing shareholders, and if all of them were used for a JV at the current stock price of $9, we'd have the following inputs for my Phase II valuation formula (updated here to account for the reverse split and proposed increase in shares):
TAM / 5 / shares outstanding = ACTC price
$5b 60M $83.33
It's important to remember that this is just an example of the valuation formula I have already suggested, not an actual valuation calculation; any of the inputs could change. Most notably, the price at which shares are placed with a partner could easily be higher or lower than the current stock price. Outside factors, such as the recent patent grant, will certainly have an impact on ACTC share price as well.
Can we really assume that?
Obviously there is going to be a lot of buying pressure on the stock as the relevance of their published data takes on its true effect. Grab now before this dip is over!
Some basics. Currently Advanced Cell has 37.5 million Approved shares, 33.4 million are outstanding. The point is, when the additional shares, if approved, the total approved will be 60 million, and we don't know the number that will be outstanding. If the value of the company increases by the same rate of outstanding shares, the effect is nondilutive. If the value of the company exceeds the present value per share, then the PPS rises. There is a lot of value in the near future events.
It's already paid. This was just a summary publication by the SEC. It summarizes what happened in the past. I guess part of their punishment plan is to state it in the present tense.
I wasn't harping on smd.....
But in the article it does mention
"Rabin, who lives in Santa Monica, Calif., and left the company earlier this year, agreed to settle the SEC’s charges by paying a $175,000 penalty. ACT agreed to pay a $375,000 penalty and retain an independent consultant to conduct a review of its Section 16(a) reporting and compliance procedures."
Every thing about the article is like a year old. Seems like only the date there is current.
If the TLD isn't published this week, and the pps holds above $11, that will tell us something.
Management buying shares would indicate absolutely zero...you should know that in some cases management buying shares is a confidence scam...at this stage let them proceed to advance by scientific advancements and proceeding to uplist etc.
So the shares today are freshly bought and sold, or are a display by the MMs?
I can't sell any shares from my scottrade account as they don't have the symbol updated.....hmmmm. Just checking to see if anyone else has this problem.
The ticker changed to ACTCD
This is more volatile than before!
I'm getting excited...they've said more than twice that a R/S will be coupled with the uplist, so I think we will see that as well....
Should be an interesting day tomorrow....